NO920441L - TNF inhibitor - Google Patents

TNF inhibitor

Info

Publication number
NO920441L
NO920441L NO92920441A NO920441A NO920441L NO 920441 L NO920441 L NO 920441L NO 92920441 A NO92920441 A NO 92920441A NO 920441 A NO920441 A NO 920441A NO 920441 L NO920441 L NO 920441L
Authority
NO
Norway
Prior art keywords
independently
group
tnf inhibitor
tnf
rrutor
Prior art date
Application number
NO92920441A
Other languages
Norwegian (no)
Other versions
NO920441D0 (en
Inventor
Klaus Max Esser
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Priority to NO92920441A priority Critical patent/NO920441L/en
Publication of NO920441D0 publication Critical patent/NO920441D0/en
Publication of NO920441L publication Critical patent/NO920441L/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives bruk av en forbindelse med formel (I):. hvor. R.og R, uavhengig av hverandre utgjør -(CH2) -A;. m er 0 eller tallet 1, 2 eller 3;. A utgjør et substituert eller usubstituert cyklisk hydrokarbonradikal;. Rutgjør et halogenatom, en nitrogruppe eller en gruppe -R;. RRutør uavhengig av hverandre, hydrogen, alkyl eller alkylkarbonyl; eller hvorog R^ sammen med nitrogenatomet som de er tilknyttet, danner en eventuelt substituert heterocyklisk gruppe; og farmasøytisk akseptable salter derav,. for fremstilling av et farmasøytisk preparat for hemming av produksjonen av tumornekrosefaktor (TNF) i pattedyr.The use of a compound of formula (I) is described:. where. R. and R, independently of one another, constitute - (CH2) -A ;. m is 0 or the number 1, 2 or 3 ;. A constitutes a substituted or unsubstituted cyclic hydrocarbon radical; Forms a halogen atom, a nitro group or a group -R ;. RRutor independently, hydrogen, alkyl or alkylcarbonyl; or wherein R 2 together with the nitrogen atom to which they are attached form an optionally substituted heterocyclic group; and pharmaceutically acceptable salts thereof,. for the manufacture of a pharmaceutical composition for inhibiting the production of tumor necrosis factor (TNF) in mammals.

NO92920441A 1992-02-03 1992-02-03 TNF inhibitor NO920441L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO92920441A NO920441L (en) 1992-02-03 1992-02-03 TNF inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO92920441A NO920441L (en) 1992-02-03 1992-02-03 TNF inhibitor

Publications (2)

Publication Number Publication Date
NO920441D0 NO920441D0 (en) 1992-02-03
NO920441L true NO920441L (en) 1993-08-04

Family

ID=19894834

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920441A NO920441L (en) 1992-02-03 1992-02-03 TNF inhibitor

Country Status (1)

Country Link
NO (1) NO920441L (en)

Also Published As

Publication number Publication date
NO920441D0 (en) 1992-02-03

Similar Documents

Publication Publication Date Title
FI813033L (en) SUBSTITUTE ACYLDERIVAT AV 1,2,3,4-TETRAHYDROISOKINOLIN-3-CARBOXYL SYROR
CA2318349A1 (en) Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
NO175592C (en) Analogous Process for the Preparation of Therapeutically Active Xanthines
NO943093L (en) Process for the preparation of clavulanic acid
BG104853A (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
DK0632036T3 (en) Amide derivatives with antipypercholesteremic activity, their preparation and their therapeutic uses
DK0567271T3 (en) Steroid derivatives for the treatment of prostate hypertrophy, method of preparation thereof and applications thereof
NO902598L (en) PROCESS AND PREPARATION OF 7-SUBSTITUTED HEPT-6-ACID AND HEPTANIC ACID AND DERIVATIVES AND INTERMEDIATES THEREOF.
DE3777852D1 (en) DEKAHYDROCHINOLIN DERIVATIVES, METHOD FOR THEIR PRODUCTION, INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, THEIR USE AS MEDICINAL PRODUCTS AND PREPARATIONS THEREOF.
DK0437030T3 (en) Use of 4-substituted imidazoles to reduce intraocular pressure
ES2007543A6 (en) 1,4-Dihydropyridines, process for their preparation and their use as medicaments.
DK196688D0 (en) BICYCLIC RELATIONS AND PROCEDURES FOR PRODUCING THEREOF
ES8609212A1 (en) Bis(beta-hydroxy phenethyl)amines.
HUP9900679A2 (en) Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation, process for producing them and pharmaceutical compositions containing them
NO920441L (en) TNF inhibitor
AU539177B2 (en) Amino alkoxy pyrazoles
DE69407042D1 (en) PSORAL DERIVATIVES, THEIR PRODUCTION AND USE AS MEDICINAL PRODUCTS
NO954654L (en) Benzimiddazolyl-diazacyklo-octane connection
GB9507288D0 (en) Phenoxyethylamine derivatives with high affinity for 5-HT1A receptors
FR2633292B1 (en) NOVEL 20,21-DINOREBURNAMENINE DERIVATIVES SUBSTITUTED IN 15 BY AN AMINE GROUP, THEIR PREPARATION METHOD AND THE INTERMEDIATES THUS OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE44741T1 (en) 2-(N-SUBSTITUTED GUANIDINO)-4HETEROARYLTHIAZOLE AS ANTI-ULCER AGENTS.
ES464250A1 (en) Esters of disubstituted isobutyric acids and pharmaceutical compositions containing the same